vs
Side-by-side financial comparison of LCNB CORP (LCNB) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
LCNB CORP is the larger business by last-quarter revenue ($23.9M vs $20.6M, roughly 1.2× Entrada Therapeutics, Inc.). LCNB CORP runs the higher net margin — 23.7% vs -84.4%, a 108.1% gap on every dollar of revenue. On growth, LCNB CORP posted the faster year-over-year revenue change (5.1% vs -65.2%). LCNB CORP produced more free cash flow last quarter ($33.4M vs $-39.7M). Over the past eight quarters, LCNB CORP's revenue compounded faster (15.7% CAGR vs 6.4%).
LCNB Corp is a United States-based financial holding company that operates through its national bank subsidiary, providing a full suite of retail and commercial banking products and services including deposit accounts, various loan products, wealth management, and insurance solutions primarily to individual consumers, small and medium-sized enterprises and local community organizations across regional markets in Ohio.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
LCNB vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.9M | $20.6M |
| Net Profit | $5.7M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | 29.2% | -106.0% |
| Net Margin | 23.7% | -84.4% |
| Revenue YoY | 5.1% | -65.2% |
| Net Profit YoY | -7.6% | -173.8% |
| EPS (diluted) | $0.40 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.9M | — | ||
| Q3 25 | $23.8M | — | ||
| Q2 25 | $22.8M | — | ||
| Q1 25 | $21.5M | $20.6M | ||
| Q4 24 | $22.7M | $37.4M | ||
| Q3 24 | $21.4M | $19.6M | ||
| Q2 24 | $19.3M | $94.7M | ||
| Q1 24 | $17.8M | $59.1M |
| Q4 25 | $5.7M | — | ||
| Q3 25 | $6.9M | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $4.6M | $-17.3M | ||
| Q4 24 | $6.1M | $1.1M | ||
| Q3 24 | $4.5M | $-14.0M | ||
| Q2 24 | $925.0K | $55.0M | ||
| Q1 24 | $1.9M | $23.5M |
| Q4 25 | 29.2% | — | ||
| Q3 25 | 35.6% | — | ||
| Q2 25 | 31.6% | — | ||
| Q1 25 | 25.6% | -106.0% | ||
| Q4 24 | 32.9% | -15.7% | ||
| Q3 24 | 24.9% | -110.7% | ||
| Q2 24 | 4.9% | 56.4% | ||
| Q1 24 | 12.5% | 35.7% |
| Q4 25 | 23.7% | — | ||
| Q3 25 | 29.1% | — | ||
| Q2 25 | 26.0% | — | ||
| Q1 25 | 21.4% | -84.4% | ||
| Q4 24 | 27.0% | 3.0% | ||
| Q3 24 | 21.2% | -71.7% | ||
| Q2 24 | 4.8% | 58.1% | ||
| Q1 24 | 10.7% | 39.7% |
| Q4 25 | $0.40 | — | ||
| Q3 25 | $0.49 | — | ||
| Q2 25 | $0.41 | — | ||
| Q1 25 | $0.33 | $-0.42 | ||
| Q4 24 | $0.44 | $-0.20 | ||
| Q3 24 | $0.31 | $-0.35 | ||
| Q2 24 | $0.07 | $1.55 | ||
| Q1 24 | $0.15 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.6M | $67.8M |
| Total DebtLower is stronger | $104.4M | — |
| Stockholders' EquityBook value | $273.9M | $417.3M |
| Total Assets | $2.2B | $486.5M |
| Debt / EquityLower = less leverage | 0.38× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.6M | — | ||
| Q3 25 | $35.9M | — | ||
| Q2 25 | $49.8M | — | ||
| Q1 25 | $37.7M | $67.8M | ||
| Q4 24 | $35.7M | $101.2M | ||
| Q3 24 | $39.4M | $78.0M | ||
| Q2 24 | $34.9M | $185.3M | ||
| Q1 24 | $33.0M | $68.4M |
| Q4 25 | $104.4M | — | ||
| Q3 25 | $104.7M | — | ||
| Q2 25 | $105.0M | — | ||
| Q1 25 | $104.6M | — | ||
| Q4 24 | $155.2M | — | ||
| Q3 24 | $155.7M | — | ||
| Q2 24 | $162.2M | — | ||
| Q1 24 | $162.6M | — |
| Q4 25 | $273.9M | — | ||
| Q3 25 | $269.9M | — | ||
| Q2 25 | $263.5M | — | ||
| Q1 25 | $258.7M | $417.3M | ||
| Q4 24 | $253.0M | $428.7M | ||
| Q3 24 | $253.2M | $422.4M | ||
| Q2 24 | $245.2M | $429.9M | ||
| Q1 24 | $233.7M | $269.4M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.3B | $486.5M | ||
| Q4 24 | $2.3B | $526.3M | ||
| Q3 24 | $2.3B | $554.6M | ||
| Q2 24 | $2.4B | $582.0M | ||
| Q1 24 | $2.3B | $510.8M |
| Q4 25 | 0.38× | — | ||
| Q3 25 | 0.39× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.66× | — | ||
| Q1 24 | 0.70× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.4M | $-38.5M |
| Free Cash FlowOCF − Capex | $33.4M | $-39.7M |
| FCF MarginFCF / Revenue | 140.2% | -192.9% |
| Capex IntensityCapex / Revenue | 4.0% | 5.6% |
| Cash ConversionOCF / Net Profit | 6.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $54.5M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.4M | — | ||
| Q3 25 | $14.0M | — | ||
| Q2 25 | $5.5M | — | ||
| Q1 25 | $2.2M | $-38.5M | ||
| Q4 24 | $93.2M | $-31.6M | ||
| Q3 24 | $11.9M | $-24.3M | ||
| Q2 24 | $54.9M | $39.8M | ||
| Q1 24 | $-11.9M | $-25.5M |
| Q4 25 | $33.4M | — | ||
| Q3 25 | $13.7M | — | ||
| Q2 25 | $5.2M | — | ||
| Q1 25 | $2.1M | $-39.7M | ||
| Q4 24 | $89.4M | $-32.2M | ||
| Q3 24 | $10.5M | $-24.9M | ||
| Q2 24 | $53.8M | $38.8M | ||
| Q1 24 | $-12.8M | $-26.4M |
| Q4 25 | 140.2% | — | ||
| Q3 25 | 57.4% | — | ||
| Q2 25 | 23.0% | — | ||
| Q1 25 | 10.0% | -192.9% | ||
| Q4 24 | 394.0% | -86.2% | ||
| Q3 24 | 49.0% | -127.3% | ||
| Q2 24 | 278.6% | 41.0% | ||
| Q1 24 | -71.8% | -44.6% |
| Q4 25 | 4.0% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.3% | 5.6% | ||
| Q4 24 | 16.7% | 1.7% | ||
| Q3 24 | 6.7% | 3.3% | ||
| Q2 24 | 5.9% | 1.1% | ||
| Q1 24 | 4.8% | 1.4% |
| Q4 25 | 6.08× | — | ||
| Q3 25 | 2.02× | — | ||
| Q2 25 | 0.92× | — | ||
| Q1 25 | 0.48× | — | ||
| Q4 24 | 15.23× | -27.94× | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 59.35× | 0.72× | ||
| Q1 24 | -6.24× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
